<p>We sat down with Dr. Greg Merrick to discuss his randomized trial presented as a plenary session at the World Congress of Brachytherapy in Washington DC.</p>

We sat down with Dr. Greg Merrick to discuss his randomized trial presented as a plenary session at the World Congress of Brachytherapy in Washington DC.

No Benefit to the Addition of External Beam to LDR Brachytherapy for Unfavorable Intermediate Risk Prostate Cancer

Welcome to the American Brachytherapy Society podcast. The ABS is an international educational and advocacy organization representing radiation oncologists dedicated to the eradication of cancer using advanced personalized techniques of interventional radiation oncology.

Share No Benefit to the Addition of External Beam to LDR Brachytherapy for Unfavorable Intermediate Risk Prostate Cancer

Sign up to save your podcasts

No Benefit to the Addition of External Beam to LDR Brachytherapy for Unfavorable Intermediate Risk Prostate Cancer

No Benefit to the Addition of External Beam to LDR Brachytherapy for Unfavorable Intermediate Risk Prostate Cancer

More shows like American Brachytherapy Society

SmartLess